Outbreak of hepatitis C virus infection in a hemodialysis unit:: Potential transmission by the hemodialysis machine?

被引:56
作者
Delarocque-Astagneau, E
Baffoy, N
Thiers, V
Simon, N
de Valk, H
Laperche, S
Couroucé, AM
Astagneau, P
Buisson, C
Desenclos, JC
机构
[1] InVS, F-94415 Paris, France
[2] Inst Biomed Cordeliers, Ctr Inter Reg Corrdinat Lutte Contre Infect Nosoco, F-75006 Paris, France
[3] Ctr Natl Reference Epidemiol Mol Hepatites Virale, Paris, France
[4] AURA, Ctr Lutte Contre Infect Nosocomiales, Paris, France
[5] European Programme Intervent Epidemiol Training, Paris, France
[6] Inst Natl Transfus Sanguine, F-75015 Paris, France
关键词
D O I
10.1086/502060
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE: To identify the routes of transmission during an outbreak of infection with hepatitis C virus (HCV) genotype 2a/2c in a hemodialysis unit. DESIGN: A matched case-control study was conducted to identify risk factors for HCV seroconversion. Direct observation and staff interviews were conducted to assess infection control practices. Molecular methods were used in a comparison of HCV infecting isolates from the case-patients and from patients infected with the 2a/2c genotype before admission to the unit. SETTING: A hemodialysis unit treating an average of 90 patients. PATIENTS: A case-patient was defined as a patient receiving hemodialysis with a seroconversion for HCV genotype 2a/2c between January 1994 and July 1997 who had received dialysis in the unit during the 3 months before the onset of disease. For each case-patient, 3 control-patients were randomly selected among all susceptible patients treated in the unit during the presumed contamination period of the case-patient. RESULTS: HCV seroconversion was associated with the number of hemodialysis sessions undergone on a machine shared with (odds ratio [OR] per additional session, 1.3; 95% confidence interval [CI95], 0.9 to 1.8) or in the same room as (OR per additional session, 1.1; CI95, 1.0 to 1.2) a patient who was anti-HCV (genotype 2a/2c) positive. We observed several breaches in infection control procedures. Wetting of transducer protectors in the external pressure tubing sets with patient blood reflux was observed, leading to a potential contamination by blood of the pressure-sensing port of the machine, which is not accessible to routine disinfection. The molecular analysis of HCV infecting isolates identified among the case-patients revealed two groups of identical isolates similar to those of two patients infected before admission to the unit. CONCLUSIONS: The results suggest patient-to-patient transmission of HCV by breaches in infection control practices and possible contamination of the machine. No additional cases have occurred since the reinforcement of infection control procedures and the use of a second transducer protector (Infect Control Hosp Epidemiol 2002;23:328-334).
引用
收藏
页码:328 / 334
页数:7
相关论文
共 37 条
[1]   Hand contamination with hepatitis C virus in staff looking after hepatitis C-positive hemodialysis patients [J].
Alfurayh, O ;
Sabeel, A ;
Al Ahdal, MN ;
Almeshari, K ;
Kessie, G ;
Hamid, M ;
Dela Cruz, DM .
AMERICAN JOURNAL OF NEPHROLOGY, 2000, 20 (02) :103-106
[2]   HEPATITIS-C TRANSMISSION IN A HEMODIALYSIS UNIT - MOLECULAR EVIDENCE FOR SPREAD OF VIRUS AMONG PATIENTS NOT SHARING EQUIPMENT [J].
ALLANDER, T ;
MEDIN, C ;
JACOBSON, SH ;
GRILLNER, L ;
PERSSON, MAA .
JOURNAL OF MEDICAL VIROLOGY, 1994, 43 (04) :415-419
[3]  
[Anonymous], 1998, Modern Epidemiology
[4]  
BLUMBERG A, 1995, NEPHROL DIAL TRANSPL, V10, P230
[5]  
COUROUCE AM, 1997, MED THER, V3, P858
[6]  
FELSENSTEIN J, 1993, PHYLIP INFERENCE PAC
[7]   PREVENTION OF HEPATITIS-C VIRUS IN DIALYSIS UNITS [J].
GILLI, P ;
SOFFRITTI, S ;
VITALI, EDP ;
BEDANI, PL .
NEPHRON, 1995, 70 (03) :301-306
[8]  
Hardy NM, 2000, CLIN NEPHROL, V54, P143
[9]   Genotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR method [J].
Holland, PV ;
Barrera, JM ;
Ercilla, MG ;
Yoshida, CFT ;
Wang, Y ;
deOlim, GAB ;
Betlach, B ;
Kuramoto, K ;
Okamoto, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (10) :2372-2378
[10]  
*HOSP INF CONTR PR, 1996, AM J INFECT CONTROL, V24, P32